Connection

David Smadja to Humans

Back to Details
This is a "connection" page, showing publications David Smadja has written about Humans.
David Smadja
Connection Strength
0.151
Humans
  1. Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality. Arthritis Rheumatol. 2021 11; 73(11):1976-1985.
    View in: PubMed
    Score: 0.008
  2. Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase. Eur Respir J. 2021 07; 58(1).
    View in: PubMed
    Score: 0.008
  3. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis. 2021 11; 24(4):755-788.
    View in: PubMed
    Score: 0.008
  4. Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality. J Thromb Haemost. 2021 07; 19(7):1823-1830.
    View in: PubMed
    Score: 0.008
  5. Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance. Angiogenesis. 2021 08; 24(3):407-411.
    View in: PubMed
    Score: 0.008
  6. Is COVID-19 a New Hematologic Disease? Stem Cell Rev Rep. 2021 02; 17(1):4-8.
    View in: PubMed
    Score: 0.007
  7. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis. 2021 08; 24(3):505-517.
    View in: PubMed
    Score: 0.007
  8. Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 Cells. Stem Cell Rev Rep. 2021 04; 17(2):639-651.
    View in: PubMed
    Score: 0.007
  9. Curative anticoagulation prevents endothelial lesion in COVID-19 patients. J Thromb Haemost. 2020 09; 18(9):2391-2399.
    View in: PubMed
    Score: 0.007
  10. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020 11; 23(4):611-620.
    View in: PubMed
    Score: 0.007
  11. Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity. Angiogenesis. 2019 05; 22(2):325-339.
    View in: PubMed
    Score: 0.006
  12. Usefulness of initial plasma dabigatran concentration to predict rebound after reversal. Haematologica. 2018 05; 103(5):e226-e229.
    View in: PubMed
    Score: 0.006
  13. A bioprosthetic total artificial heart for end-stage heart failure: Results from a pilot study. J Heart Lung Transplant. 2018 01; 37(1):33-37.
    View in: PubMed
    Score: 0.006
  14. Bioprosthetic Total Artificial Heart Induces a Profile of Acquired Hemocompatibility With Membranes Recellularization. J Am Coll Cardiol. 2017 07 18; 70(3):404-406.
    View in: PubMed
    Score: 0.006
  15. Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells. Thromb Haemost. 2015 Oct; 114(4):735-47.
    View in: PubMed
    Score: 0.005
  16. Forearm ischemia decreases endothelial colony-forming cell angiogenic potential. Cytotherapy. 2014 Feb; 16(2):213-24.
    View in: PubMed
    Score: 0.005
  17. Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening. PLoS One. 2013; 8(6):e65114.
    View in: PubMed
    Score: 0.004
  18. [Characterization of endothelial progenitor cells and putative strategies to improve their expansion]. J Soc Biol. 2009; 203(2):197-207.
    View in: PubMed
    Score: 0.003
  19. Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock. Crit Care Med. 2021 11 01; 49(11):e1151-e1156.
    View in: PubMed
    Score: 0.002
  20. Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine. Front Immunol. 2021; 12:701273.
    View in: PubMed
    Score: 0.002
  21. Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity. PLoS One. 2021; 16(5):e0252026.
    View in: PubMed
    Score: 0.002
  22. D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study. Arch Cardiovasc Dis. 2021 May; 114(5):381-393.
    View in: PubMed
    Score: 0.002
  23. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study. J Am Heart Assoc. 2021 04 20; 10(8):e018624.
    View in: PubMed
    Score: 0.002
  24. No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19. Oncoimmunology. 2020 12 08; 9(1):1857112.
    View in: PubMed
    Score: 0.002
  25. Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study. Thromb Res. 2021 01; 197:94-99.
    View in: PubMed
    Score: 0.002
  26. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020 10 23; 370(6515).
    View in: PubMed
    Score: 0.002
  27. [Recommendations for best practice in the management of venous thromboembolic disease in adults. Long version]. Rev Mal Respir. 2021 04; 38 Suppl 1:e1-e6.
    View in: PubMed
    Score: 0.002
  28. Recipients with blood group A associated with longer survival rates in cardiac valvular bioprostheses. EBioMedicine. 2019 Apr; 42:54-63.
    View in: PubMed
    Score: 0.002
  29. [Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version]. Rev Mal Respir. 2019 Feb; 36(2):249-283.
    View in: PubMed
    Score: 0.002
  30. [Venous thromboembolism and urological cancer: Epidemiology and therapeutically management]. Prog Urol. 2019 Jan; 29(1):1-11.
    View in: PubMed
    Score: 0.002
  31. Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month. PLoS One. 2018; 13(8):e0200364.
    View in: PubMed
    Score: 0.002
  32. Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support. J Am Coll Cardiol. 2018 05 15; 71(19):2106-2118.
    View in: PubMed
    Score: 0.002
  33. Human endoglin as a potential new partner involved in platelet-endothelium interactions. Cell Mol Life Sci. 2018 04; 75(7):1269-1284.
    View in: PubMed
    Score: 0.001
  34. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia. Expert Opin Ther Targets. 2017 10; 21(10):933-947.
    View in: PubMed
    Score: 0.001
  35. [State of the art: Direct oral anticoagulants and transfusion]. Transfus Clin Biol. 2017 Sep; 24(3):154-159.
    View in: PubMed
    Score: 0.001
  36. Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia. Exp Hematol. 2017 09; 53:48-58.
    View in: PubMed
    Score: 0.001
  37. [The role of extracorporeal removal of CO2 (ECCO2R) in the management of respiratory diseases]. Rev Mal Respir. 2017 Jun; 34(6):598-606.
    View in: PubMed
    Score: 0.001
  38. PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study. Blood. 2016 12 08; 128(23):e59-e66.
    View in: PubMed
    Score: 0.001
  39. Postischemic revascularization: from cellular and molecular mechanisms to clinical applications. Physiol Rev. 2013 Oct; 93(4):1743-802.
    View in: PubMed
    Score: 0.001
  40. Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger's disease) exacerbation. J Cell Mol Med. 2010 Jan; 14(1-2):449-51.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.